Literature DB >> 34902824

NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.

Chrysalyne D Schmults1, Rachel Blitzblau2, Sumaira Z Aasi3, Murad Alam4, James S Andersen5, Brian C Baumann6, Jeremy Bordeaux7, Pei-Ling Chen8, Robert Chin9, Carlo M Contreras10, Dominick DiMaio11, Jessica M Donigan12, Jeffrey M Farma13, Karthik Ghosh14, Roy C Grekin15, Kelly Harms16, Alan L Ho17, Ashley Holder18, John Nicholas Lukens19, Theresa Medina20, Kishwer S Nehal17, Paul Nghiem21, Soo Park22, Tejesh Patel23, Igor Puzanov24, Jeffrey Scott25, Aleksandar Sekulic14, Ashok R Shaha17, Divya Srivastava26, William Stebbins27, Valencia Thomas28, Yaohui G Xu29, Beth McCullough30, Mary A Dwyer30, Mai Q Nguyen30.   

Abstract

The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for diagnostic workup, clinical stage, and treatment options for patients with cutaneous squamous cell carcinoma. The NCCN panel meets annually to discuss updates to the guidelines based on comments from panel members and the Institutional Review, as well as submissions from within NCCN and external organizations. These NCCN Guidelines Insights focus on the introduction of a new surgical recommendation terminology (peripheral and deep en face margin assessment), as well as recent updates on topical prophylaxis, immunotherapy for regional and metastatic disease, and radiation therapy.

Entities:  

Mesh:

Year:  2021        PMID: 34902824     DOI: 10.6004/jnccn.2021.0059

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  9 in total

1.  Primary Eccrine Porocarcinoma of the Breast: A Case Report and Review of Literature.

Authors:  Yi Xin Li; Mihir Gudi; Zhiyan Yan
Journal:  Case Rep Oncol Med       Date:  2022-05-31

Review 2.  Nail Cancer: Review of the Two Main Types of an Underestimated Disease.

Authors:  Camilo Levi Acuña Pinzon; Jefferson Fabian Nieves Condoy; Daniel A Rivera Marquez; Alan Ramón Javier Collazo Moreno; Roland Kevin Cethorth Fonseca; Luis Abraham Zúñiga Vázquez
Journal:  Cureus       Date:  2022-04-05

3.  The Effect of Tumor Characteristics and Location on the Extent of Lymph Node Metastases of Head and Neck Cutaneous Squamous Cell Carcinoma.

Authors:  Bram van Leer; Alet J G Leus; Boukje A C van Dijk; Marloes S van Kester; Gyorgy B Halmos; Gilles F H Diercks; Bert van der Vegt; Jeroen Vister; Emoke Rácz; Boudewijn E C Plaat
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

4.  Challenges in diagnosis and management of perineal hypospadias with a testicular seminoma mimicking paratesticular tumor in a solitary testis: A case report.

Authors:  Ramlan Nasution; Ali Husein; Lidya Imelda Laksmi; Belman Novenry Silalahi
Journal:  Urol Case Rep       Date:  2022-03-16

Review 5.  The Contributions of Cancer-Testis and Developmental Genes to the Pathogenesis of Keratinocyte Carcinomas.

Authors:  Brandon Ramchatesingh; Jennifer Gantchev; Amelia Martínez Villarreal; Raman Preet Kaur Gill; Marine Lambert; Sriraam Sivachandran; Philippe Lefrançois; Ivan V Litvinov
Journal:  Cancers (Basel)       Date:  2022-07-26       Impact factor: 6.575

Review 6.  Evidence from Clinical Studies Related to Dermatologic Surgeries for Skin Cancer.

Authors:  Shoichiro Ishizuki; Yoshiyuki Nakamura
Journal:  Cancers (Basel)       Date:  2022-08-08       Impact factor: 6.575

Review 7.  Recent Advances in the Diagnosis and Management of High-Risk Cutaneous Squamous Cell Carcinoma.

Authors:  Clio Dessinioti; Alexander J Stratigos
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

8.  Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.

Authors:  Sibylle Loibl; Chiun-Sheng Huang; Max S Mano; Eleftherios P Mamounas; Charles E Geyer; Michael Untch; Jean-Christophe Thery; Ingo Schwaner; Steven Limentani; Niklas Loman; Kristina Lübbe; Jenny C Chang; Thomas Hatschek; David Tesarowski; Chunyan Song; Sanne Lysbet de Haas; Thomas Boulet; Chiara Lambertini; Norman Wolmark
Journal:  NPJ Breast Cancer       Date:  2022-09-19

9.  Wild-type IDH1 inhibition enhances chemotherapy response in melanoma.

Authors:  Mehrdad Zarei; Omid Hajihassani; Jonathan J Hue; Hallie J Graor; Alexander W Loftus; Moeez Rathore; Ali Vaziri-Gohar; John M Asara; Jordan M Winter; Luke D Rothermel
Journal:  J Exp Clin Cancer Res       Date:  2022-09-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.